Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlumasc Group Regulatory News (ALU)

Share Price Information for Alumasc Group (ALU)

Share Price is delayed by 15 minutes
Get Live Data
240.00    5.00 (2.13%)
Bid:
235.00
Ask:
245.00
Spread: 10.00 (4.255%)
Market Cap: £86.30m
ALU Live PriceLast checked at - London Stock Exchange

Intraday Alumasc Group Share Chart

Trading Statement

19 Jan 2021 07:00

RNS Number : 0821M
Alumasc Group PLC
19 January 2021
 

19 January 2021

THE ALUMASC GROUP PLC

("ALUMASC")

TRADING UPDATE FOR SIX MONTHS ENDED 31 DECEMBER 2020

 

Alumasc, the premium building products, systems, and solutions Group, today provides a trading update for the six months ended 31 December 2020, ahead of publication of its half-year results on Thursday 4 February 2021.

Our absolute focus continues to be the safety of our employees, customers, suppliers, and sub-contractors as we continue to manage with the Covid-19 pandemic and the latest lockdown guidelines.

Record Half Year Performance

Further to our AGM Trading Update on 22 October 2020, which reported a strong performance in the first quarter, we are very pleased to report that conditions in our markets have remained positive and that the Group's trading performance has continued through to the end of the first half of the financial year, with a record profit for the period being achieved. On an unaudited basis, for the first six months of the year:

· Revenue increased 11% versus the prior year to £45.6m

· Underlying PBT increased significantly, from £2.3m to £6.0m

· Cash generation has also been strong in the first half, with net bank debt reducing from £4.3m at 30 June 2020 to £0.2m at 31 December 2020.

 

Pleasingly, all our divisions have contributed to the strong performance. While trading in the period includes an element of catch-up demand following the UK's first national lockdown and has benefitted from a range of Government support for the construction industry, our businesses have also been successful in winning market share and have been further supported by encouraging export sales. Additionally, the restructuring during FY2020, which provided £2.4 million in annual cost savings, benefitted margins. Levolux also continues to respond well to the business's turnaround plan, achieving a profit in each month of the first half of this financial year.

Outlook

The business has entered H2 with good momentum, a healthy forward sales position, and a well-capitalised balance sheet, creating the potential to deliver a strong result for the year. Nevertheless, we remain mindful of the continued economic uncertainties, particularly the risk of disruption to our business and markets in the near term as a result of the on-going pandemic and the establishment of efficient cross-border goods movement following the entry into the Free Trade Agreement with the EU. Conditions in our markets, particularly in the new build housing and RMI sectors, have been very supportive coming into the second half and we would anticipate demand remaining good through the coming months. We are also continuing to monitor the potential impact of changes to UK Government incentives within the housebuilding industry, notably around the current Help to Buy Scheme being extended beyond 28 February 2021 and Stamp Duty and changes here may affect our final quarter, albeit the potential impact is difficult to predict. However, we are encouraged by the UK's accelerating rollout of vaccines and mass testing, which should provide some counterbalance in our markets. Overall, this has been a most encouraging performance by Alumasc in the first half and there is an excellent platform to deliver sustainable shareholder value.

Paul Hooper, CEO, commented, "It is very encouraging to see Alumasc's achievement of a double digit growth in revenues and also a double digit return on sales and H1 has absolutely shown the great potential for the Group. In light of the businesses' momentum and strong cash conversion, a resumption of Alumasc's previous dividend policy is being considered by the Board."

This announcement contains inside information.

Enquiries:

Paul Hooper, CEO

Helen Ashton, Group Company Secretary

+ 44 (0) 1536 383844

+ 44 (0) 1536 383812

 

Peel Hunt (Broker)

Mike Bell + 44 (0)207 418 8831

 

finnCap (NOMAD)

Julian Blunt + 44 (0)207 220 0561

Camarco:

Ginny Pulbrook + 44 (0)203 757 4992

Tom Huddart + 44 (0)203 757 4991

Email: alumasc@camarco.co.uk

 

 

Notes to Editors:

Alumasc is a UK-based supplier of premium building products, systems and solutions. Almost 80% of group sales are driven by building regulations and specifications (architects and structural engineers) because of the performance characteristics offered.

 

The Group has three business segments with strong positions and brands in their individual markets. The three segments are: Water Management; Building Envelope; and Housebuilding Products.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFSRLFITLIL
Date   Source Headline
4th May 20163:31 pmRNSHolding(s) in Company
21st Mar 20162:35 pmRNSDirector/PDMR Shareholding
9th Mar 20169:38 amRNSHolding(s) in Company
7th Mar 20164:22 pmRNSDirector/PDMR Shareholding
2nd Feb 20167:00 amRNSHalf Yearly Report
8th Jan 20167:00 amRNSNotice of Results
10th Dec 20153:53 pmRNSDirector/PDMR Shareholding
11th Nov 20153:16 pmRNSHolding(s) in Company
23rd Oct 20153:07 pmRNSResult of AGM
22nd Oct 20157:00 amRNSAGM Statement
15th Oct 20157:00 amRNSLevolux wins £3m order in the USA
23rd Sep 20154:50 pmRNSHolding(s) in Company
22nd Sep 20151:45 pmRNSHolding(s) in Company
9th Sep 20152:04 pmRNSHolding(s) in Company
8th Sep 20154:22 pmRNSHolding(s) in Company
7th Sep 20153:50 pmRNSHolding(s) in Company
3rd Sep 20157:00 amRNSAnnual Financial Report
1st Sep 20154:08 pmRNSHolding(s) in Company
13th Jul 20157:00 amRNSNotice of Results
6th Jul 20154:20 pmRNSHolding(s) in Company
26th Jun 20155:34 pmRNSDisposal of APC & Trading Update
2nd Apr 20152:03 pmRNSDirector/PDMR Shareholding
13th Mar 20152:10 pmRNSDirector/PDMR Shareholding
10th Mar 20159:42 amRNSDirector/PDMR Shareholding
2nd Mar 201512:48 pmRNSTR-1: Notification of Major Interest in Shares
13th Feb 20153:25 pmRNSDirector/PDMR Shareholding
3rd Feb 20157:00 amRNSHalf Yearly Report
14th Jan 20157:00 amRNSNotice of Results
21st Nov 20142:06 pmRNSTR1 Notification
30th Oct 20144:30 pmRNSResult of AGM
30th Oct 20147:00 amRNSInterim Management Statement
13th Oct 20141:46 pmRNSDirector/PDMR Shareholding
1st Oct 20148:00 amRNSDisposal
3rd Sep 20144:13 pmRNSHolding(s) in Company
2nd Sep 20147:01 amRNSFinal Results
2nd Sep 20147:00 amRNSDirectorate Change
8th Aug 20147:00 amRNSNotice of Results
24th Jun 20144:29 pmRNSDirector/PDMR Shareholding
16th May 20147:00 amRNSInterim Management Statement
11th Apr 20147:00 amRNSMajor Order
12th Mar 20144:19 pmRNSDirector/PDMR Shareholding
4th Feb 20147:00 amRNSInterim Results
8th Jan 20148:56 amRNSInterim Date Notification
24th Oct 20134:17 pmRNSResult of AGM
24th Oct 20137:00 amRNSInterim Management Statement
14th Oct 20133:21 pmRNSDirector/PDMR Shareholding
3rd Sep 20137:00 amRNSANNUAL RESULTS ANNOUNCEMENT
12th Jul 20137:00 amRNSTrading Statement
15th May 20137:00 amRNSInterim Management Statement
19th Mar 20134:16 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.